Braxia Scientific (CSE: BRAX – OTCQB: SHRMF) CEO Roger McIntyre joined Steve Darling from Proactive to bring news the company is working with Neurotherapy Montreal tp open a state of the art 14,000 square foot facility providing leading mental health and rehabilitation services using novel Ketamine Therapy. The centre is led by psychiatrists, nurses for patients diagnosed with injuries that also result in major depression and several mood disorders.
This agreement marks the opening of the Company’s fourth clinic in Canada McIntyre also told proactive the company has announced that it has changed its name to Braxia Scientific Corp. The Canadian ticker symbol will change from "SHRM" to "BRAX" on the Canadian Securities Exchange and BRAXF on the OTCQB.